These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 6212538)
1. Reversal of povidone-iodine-induced suppressor cell activity by sodium borohydride. Ninnemann JL; Morrison L Immunol Lett; 1982 Apr; 4(4):189-92. PubMed ID: 6212538 [TBL] [Abstract][Full Text] [Related]
2. Suppressor cell induction by povidone-iodine: in vitro demonstration of a consequence of clinical burn treatment with betadine. Ninnemann JL; Stein MD J Immunol; 1981 May; 126(5):1905-8. PubMed ID: 6452480 [No Abstract] [Full Text] [Related]
3. The influence of povidone-iodine treatment on thyroid hormones in severe burns. Balogh D; Bauer M; Riccabona G J Hosp Infect; 1985 Mar; 6 Suppl A():147-53. PubMed ID: 2860161 [TBL] [Abstract][Full Text] [Related]
4. [In vitro and in vivo studies of the use of betadine (Betaisadone) in burn wounds]. Zietkiewicz W; Nasiłowski W; Brudzyńska-Charewicz S; Serafińska D; Bukowska D; Rudowski W Pol Tyg Lek; 1978 Oct; 33(43):1695-7. PubMed ID: 714771 [No Abstract] [Full Text] [Related]
5. A new povidone-iodine cream for the treatment of burns. Comparison with a standard topical regimen. de Kock M; van der Merwe AE; Houghton FC S Afr Med J; 1986 Mar; 69(7):431-5. PubMed ID: 3961634 [TBL] [Abstract][Full Text] [Related]
6. A critical evaluation of povidone-iodine absorption in thermally injured patients. Hunt JL; Sato R; Heck EL; Baxter CR J Trauma; 1980 Feb; 20(2):127-9. PubMed ID: 7354494 [TBL] [Abstract][Full Text] [Related]
7. [Changes in iodine metabolism in patients with burns treated topically with PVP-iodine]. Bugyi S; Steen M; Zellner PR; Glöbel B; Andres C Unfallchirurgie; 1985 Apr; 11(2):58-64. PubMed ID: 4002421 [TBL] [Abstract][Full Text] [Related]
8. Betadine ointment for burn care in the community hospital. Barr LL J Am Osteopath Assoc; 1977 Feb; 76(6):458-61. PubMed ID: 584234 [No Abstract] [Full Text] [Related]
9. Induction of hyperthyroidism in burn patients treated topically with povidone-iodine. Rath T; Meissl G Burns Incl Therm Inj; 1988 Aug; 14(4):320-2. PubMed ID: 3224302 [TBL] [Abstract][Full Text] [Related]
11. Povidone-iodine preparations for burn wounds. Read JM S Afr Med J; 1986 May; 69(11):666. PubMed ID: 3704850 [No Abstract] [Full Text] [Related]
12. Protein-linked iodotyrosines in serum after topical application of povidone-iodine (Betadine). Alexander NM; Nishimoto M J Clin Endocrinol Metab; 1981 Jul; 53(1):105-8. PubMed ID: 6165730 [TBL] [Abstract][Full Text] [Related]
13. Nursing experience in the development and use of betadine helifoam solution. Leeder CJ Scand J Plast Reconstr Surg; 1979; 13(1):103-4. PubMed ID: 451460 [No Abstract] [Full Text] [Related]
14. Comparison of blood serum iodine levels with use of Iodoplex and povidone iodine ointment. Notea E; Hirshowitz B J Trauma; 1985 Mar; 25(3):247-9. PubMed ID: 3838560 [TBL] [Abstract][Full Text] [Related]
15. Interaction of povidone-iodine compounds, phagocytic cells, and microorganisms. Van den Broek PJ; Buys LF; Van Furth R Antimicrob Agents Chemother; 1982 Oct; 22(4):593-7. PubMed ID: 7181472 [TBL] [Abstract][Full Text] [Related]
16. Inactivation of human immunodeficiency virus by Betadine products and chlorhexidine. Harbison MA; Hammer SM J Acquir Immune Defic Syndr (1988); 1989; 2(1):16-20. PubMed ID: 2465403 [TBL] [Abstract][Full Text] [Related]